Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Determination of IDH1, IDH2, MGMT, TERT and ATRX Gene Mutations in Glial Tumors.

In vivo (Athens, Greece) - 1 Jan 2000

Yaltirik Cumhur Kaan, Yilmaz Seda Gulec, Ozdogan Selcuk, Bilgin Ezel Yaltirik, Barut Zerrin, Ture Ugur, Isbir Turgay

Abstract excerpt

BACKGROUND/AIM: The most frequent and dangerous kind of primary brain tumor is glioblastoma multiforme (GBM). The survival rates associated with GBM are very short and molecular markers for predicting survival are needed. The aim of our study was to evaluate isocitrate dehydrogenase 1 and 2 (IDH1, IDH2), telomerase reverse transcriptase (TERT), O-6- methylguanine-DNA methyltransferase (MGMT) and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to DNA Modification Methylases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Repair Enzymes

Share to Glioblastoma

Share to Glioma

Share to Isocitrate Dehydrogenase

Share to Telomerase

Share to X-linked Nuclear Protein

Source

Open in PubMed Open full text

Identifiers

PMID: 35738587
DOI: 10.21873/invivo.12881
PMCID: PMC9301419

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Determination of IDH1, IDH2, MGMT, TERT and ATRX Gene Mutations in Glial Tumors.PMID 35738587Read ↗

New Molecular Considerations for Glioma: IDH, ATRX, BRAF, TERT, H3 K27M.Semantic proximity Read ↗

Genomic Profiling in Glioma Patients to Explore Clinically Relevant Markers.Semantic proximity Read ↗

Molecular Study of Long-Term Survivors of Glioblastoma by Gene-Targeted Next-Generation Sequencing.Semantic proximity Read ↗

Study of Molecular Markers in Glioma and Their Association with Clinicopathological Features.Semantic proximity Read ↗

Molecular Testing of Brain TumorSemantic proximity Read ↗

Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma.Semantic proximity Read ↗

Molecular Classification Defines 4 Prognostically Distinct Glioma Groups Irrespective of Diagnosis and GradeSemantic proximity Read ↗

Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas.Semantic proximity Read ↗

Immunohistochemical Expression of IDH1, ATRX, Ki67, GFAP, and Prognosis in Indonesian Glioma PatientsSemantic proximity Read ↗

GLIOBLASTOMA MULTIFORME: A META-ANALYSIS OF DRIVER GENES, CURRENT DIAGNOSIS, AND TUMOR HETEROGENEITYSemantic proximity Read ↗

Gliomas molecular markers: importance in treatment, prognosis and applicability in brazilian health system.Semantic proximity Read ↗

Molecular Genetics of GliomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.